Simona Borstnar
Overview
Explore the profile of Simona Borstnar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
419
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dobovisek L, Borstnar S, Debeljak N, Brezar S
Front Immunol
. 2024 Aug;
15:1386548.
PMID: 39176080
Triple-negative breast cancer (TNBC) accounts for about 10-20% of all breast cancer cases and is associated with an unfavorable prognosis. Until recently, treatment options for TNBC were limited to chemotherapy....
2.
Borstnar S, Bozovic-Spasojevic I, Cvetanovic A, Dedic Plavetic N, Konsoulova A, Matos E, et al.
Radiol Oncol
. 2024 Jun;
58(2):258-267.
PMID: 38860691
Background: Recent evidence brought by novel anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugates is leading to significant changes in HER2-negative breast cancer (BC) best practices. A new targetable...
3.
Azim Jr H, Niman S, Partridge A, Demeestere I, Ruggeri M, Colleoni M, et al.
J Clin Oncol
. 2024 May;
42(23):2822-2832.
PMID: 38810178
Purpose: We investigated time to pregnancy, efficacy and safety of fertility preservation, and assisted reproductive technologies (ARTs) in women with early hormone receptor-positive breast cancer (BC) desiring future pregnancy. Patients...
4.
Mirosevic S, Prins J, Besic N, Borstnar S, Smrdel A, Homar V, et al.
Zdr Varst
. 2023 Dec;
63(1):55-62.
PMID: 38156338
Background: Although anxiety and depression are important determinants of mental health, the literature in this area is sparse as most studies focus on the period during treatment. Mental health problems...
5.
Cencelj Arnez R, Besic N, Mavric Z, Mozetic A, Zagar T, Homar V, et al.
Med Sci Monit
. 2023 Dec;
29:e942272.
PMID: 38041401
BACKGROUND Cigarette smoking affects cancer risk and cardiovascular risk. Smoking cessation is very beneficial for health. This study aimed to evaluate an early individualized integrated rehabilitation program and standard rehabilitation...
6.
Pislar N, Gasljevic G, Marolt Music M, Borstnar S, Zgajnar J, Perhavec A
World J Surg Oncol
. 2023 Sep;
21(1):292.
PMID: 37715188
Background: In node-positive breast cancer patients at diagnosis (cN +) that render node-negative after neoadjuvant systemic treatment (NAST), axillary lymph node dissection (ALND) can be avoided in selected cases. Axillary...
7.
Partridge A, Niman S, Ruggeri M, Peccatori F, Azim Jr H, Colleoni M, et al.
N Engl J Med
. 2023 May;
388(18):1645-1656.
PMID: 37133584
Background: Prospective data on the risk of recurrence among women with hormone receptor-positive early breast cancer who temporarily discontinue endocrine therapy to attempt pregnancy are lacking. Methods: We conducted a...
8.
Grasic Kuhar C, Borstnar S, Gazic B, Matos E
Breast
. 2023 Feb;
69:481-490.
PMID: 36740512
Aim: To assess real-world outcomes and prognostic factors of non-metastatic inflammatory breast cancer according to immunohistochemistry (IHC)-based subtype and treatment regimen. Methods: An institutional retrospective analysis of patients treated with...
9.
Mirosevic S, Prins J, Borstnar S, Besic N, Homar V, Selic-Zupancic P, et al.
Front Psychol
. 2022 Oct;
13:969918.
PMID: 36262447
Objective: To assess the prevalence of unmet needs in post-treatment breast cancer survivors and identify sociodemographic, clinical, and psychosocial variables associated with reported unmet needs during the COVID-19 pandemic. Materials...
10.
Borstnar S, Palacova M, Lacko A, Timcheva C, Nili Gal-Yam E, Papazisis K, et al.
Radiol Oncol
. 2022 May;
56(2):238-247.
PMID: 35575587
Background: The CDK4/6 inhibitor, ribociclib in combination with endocrine therapy significantly improved progression-free survival in the first line setting in post-menopausal patients with HR+/HER2- advanced breast cancer (ABC) in a...